Debut and Natura Partner on AI Discovered Skin Longevity Ingredient for Latin America

May 27, 2026
Debut and Natura have announced a partnership to commercialize an AI discovered skin longevity ingredient complex, combining Debut’s biotechnology platform with Natura’s Amazonian bioactives expertise. Products could launch as early as 2027 following clinical validation.

Debut and Natura have announced a strategic partnership to commercialize an AI discovered skin longevity ingredient complex, according to a press release. The collaboration combines Debut’s AI based biotechnology platform with Natura’s experience in Amazonian bioactives to develop new beauty products focused on skin longevity.

Debut will contribute its proprietary AI for ingredient discovery, while Natura will integrate its knowledge of Amazon biodiversity and bioactive botanicals. The companies plan to commercialize the AI discovered complex after successful clinical validation.

The ingredient complex will unite Debut’s novel actives with Natura’s natural botanicals to target biological factors that influence skin aging. Products featuring the complex could be introduced as soon as 2027.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.